For Immediate Release
London, UK (October 12, 2022) – The Society for Laboratory Automation and Screening, (SLAS) hosted five start-up life sciences companies at an Innovation AveNEW section of the ELRIG Drug Discovery 2022 conference, October 4-5.
Innovation AveNEW is a part of the SLAS Ignite initiative that promotes start-up and emerging life sciences companies, providing critical global exposure to their products and services. Innovation AveNEW also promotes collaboration and enables scientists, academic researchers and business development professionals to build connections that result in pioneering new research, new products, innovative breakthroughs and commercialization opportunities for all involved.
Listed alphabetically, the following companies participated in Innovation AveNEW at ELRIG Drug Discovery 2022:
SLAS sponsors the Innovation AveNEW at its annual international conference and exhibition in the U.S., its Europe conference and exhibition, and at select affiliated events such as ELRIG Drug Discovery and BioSpain. For more information about SLAS’s Ignite program and Innovation AveNEW opportunities for start-ups, visit https://www.slas.org/education/slas-ignite/. For more information about SLAS, visit www.SLAS.org or contact SLAS Global Headquarters at +1.877.990.SLAS(5727) or e-mail email@example.com.
The Society for Laboratory Automation and Screening (SLAS) is an international professional society of academic, industry and government life sciences researchers coupled with the developers and providers of laboratory automation technology. SLAS advances scientific innovation by providing education, collaboration and professional development that unites scientists across disciplines to transform research.
Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103